Juva Life (TSE:JUVA) has released an update.
Juva Life Inc., a life sciences company specializing in pharmaceutical research and cannabis production, has announced a delay in submitting its annual financial statements due to additional audit time required after a company reorganization. The firm is under a management cease trade order, restricting its CEO and CFO from trading company securities until the statements are filed, which is expected by June 28, 2024. Juva Life has committed to providing bi-weekly updates and confirms no other undisclosed material information.
For further insights into TSE:JUVA stock, check out TipRanks’ Stock Analysis page.
